Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group

被引：2

作者：

Lew-Derivry, Lucille ^{[1
]}

Marceau-Renaut, Alice ^{[2
]}

Fenwarth, Laurene ^{[2
,3
]}

Cuccuini, Wendy ^{[4
]}

Ballerini, Paola ^{[5
]}

Ferreboeuf, Maxime ^{[1
]}

Guilmatre, Audrey ^{[1
]}

Petit, Arnaud ^{[1
,6
]}

Gandemer, Virginie ^{[7
]}

Rialland, Fanny ^{[8
]}

Schneider, Pascale ^{[9
]}

Michel, Gerard ^{[10
]}

Bertrand, Yves ^{[11
]}

Baruchel, Andre ^{[12
]}

Preudhomme, Claude ^{[2
,3
]}

Leverger, Guy ^{[1
,6
]}

Lapillonne, Helene ^{[5
,6
]}

机构：

[1] Trousseau Hosp, AP HP, Pediat Hematol & Oncol Dept, F-75012 Paris, France

[2] CHU Lille, Lab Hematol, F-59000 Lille, France

[3] INSERM, UMR S 1172, F-59000 Lille, France

[4] St Louis Hosp, AP HP, Dept Cytogenet, F-75010 Paris, France

[5] Trousseau Hosp, AP HP, Lab Hematol, F-75012 Paris, France

[6] Sorbonne Univ, Ctr Rech St Antoine CRSA, INSERM, UMRS 938, F-75012 Paris, France

[7] Univ Hosp Rennes, Dept Pediat Hematol Oncol, F-35000 Rennes, France

[8] Univ Hosp Nantes, Dept Pediat Hematol Oncol, F-44000 Nantes, France

[9] Univ Hosp Charles Nicolle, Dept Pediat Hematol Oncol, F-76000 Rouen, France

[10] La Timone Univ Hosp, AP HM, Dept Pediat Hematol, F-13000 Marseille, France

[11] Hosp Civils Lyon, Inst Hematol & Oncol Pediat, F-69000 Lyon, France

[12] Robert Debre Univ Hosp, AP HP, Dept Pediat Hematol & Immunol, F-75019 Paris, France

来源：

LEUKEMIA | 2023年 / 37卷 / 08期

关键词：

RECOMMENDATIONS; AML;

D O I：

10.1038/s41375-023-01931-y

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1723 / 1726

页数：4

共 50 条

[41] TdT plus Acute Myeloid Leukemia is enriched for mutations of RUNX1, BCOR, and ASXL1
Bailey, Nathanael
Carlsen, Eric
Wild, Matthew
Liu, Yen-Chun
Djokic, Miroslav
LABORATORY INVESTIGATION, 2019, 99
[42] Investigations of the prognostic value of RUNX1 mutation in acute myeloid leukemia patients: Data from a real-world study
Wan, Chao-Ling
Huang, Yuan-Hong
Huang, Si-Man
Xu, Yan-Li
Tan, Kai-Wen
Yan-Qiu
Shen, Xiang-Dong
Ge, Shuai-Shuai
Cao, Han-Yu
Li, Yan-Yan
Liu, Song-Bai
Qi, Jia-Jun
Dai, Hai-Ping
Xue, Sheng-Li
LEUKEMIA RESEARCH, 2024, 139
[43] TdT plus Acute Myeloid Leukemia is enriched for mutations of RUNX1, BCOR, and ASXL1
Bailey, Nathanael
Carlsen, Eric
Wild, Matthew
Liu, Yen-Chun
Djokic, Miroslav
MODERN PATHOLOGY, 2019, 32
[44] Prevalence and Prognostic Impact of RUNX1 Mutations In Patients with Acute Myeloid Leukemia (AML): A Study In 1649 Patients Registered In the AML96 Protocol of the DSIL/SAL
Gerstenberger, Katharina
Roellig, Christoph
Schaich, Markus
Illmer, Thomas
Platzbecker, Uwe
Bornhaeuser, Martin
Ehninger, Gerhard
Thiede, Christian
BLOOD, 2010, 116 (21) : 331 - 332
[45] UNFAVORABLE PROGNOSTIC IMPACT OF WT1 MUTATIONS IN PEDIATRIC ACUTE MYELOID LEUKEMIA IN KOREA
Han, D.
Baek, H.
Jang, H.
Son, M.
Lee, S.
Yoo, K.
Sung, K.
Koo, H.
Park, J.
Hwang, T.
Kook, H.
HAEMATOLOGICA, 2013, 98 : 514 - 514
[46] De Novo Acute Myeloid Leukemia (AML) with RUNX1 Mutations Shows Characteristic Clinicopathologic Features
Quesada, Andres
Luthra, Rajyalakshmi
Patel, Keyur P.
Singh, Rajesh
Routbort, Mark
Loghavi, Sanam
Khoury, Joseph D.
Medeiros, Jeffrey
Bueso-Ramos, Carlos E.
Kanagal-Shamanna, Rashmi
MODERN PATHOLOGY, 2016, 29 : 371A - 371A
[47] Familial Acute Myeloid Leukemia/Myelodysplastic Syndrome with Germline RUNX1 Mutations: A Single Instituion Experience
Hathuc, Vivian
Walkovich, Kelly
Bixby, Dale
Shao, Lina
Smith, Lauren
LABORATORY INVESTIGATION, 2017, 97 : 467A - 467A
[48] Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia
Roman Hornung
Vindi Jurinovic
Aarif M. N. Batcha
Stefanos A. Bamopoulos
Maja Rothenberg-Thurley
Susanne Amler
Maria Cristina Sauerland
Wolfgang E. Berdel
Bernhard J. Wörmann
Stefan K. Bohlander
Jan Braess
Wolfgang Hiddemann
Sören Lehmann
Sylvain Mareschal
Karsten Spiekermann
Klaus H. Metzeler
Tobias Herold
Anne-Laure Boulesteix
Scientific Reports, 8
[49] RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features
V I Gaidzik
V Teleanu
E Papaemmanuil
D Weber
P Paschka
J Hahn
T Wallrabenstein
B Kolbinger
C H Köhne
H A Horst
P Brossart
G Held
A Kündgen
M Ringhoffer
K Götze
M Rummel
M Gerstung
P Campbell
J M Kraus
H A Kestler
F Thol
M Heuser
B Schlegelberger
A Ganser
L Bullinger
R F Schlenk
K Döhner
H Döhner
Leukemia, 2016, 30 : 2160 - 2168
[50] Frequent RUNX1 and TP53 Mutations in Secondary Acute Myeloid Leukemia with Mixed Phenotype
Galera, Pallavi
Baik, Jeeyeon
Famulare, Christopher
Sigler, Allison
Zhang, Yanming
Arcila, Maria
Dogan, Ahmet
Tallman, Martin
Levine, Ross
Glass, Jacob
Roshal, Mikhail
Xiao, Wenbin
LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1293 - 1294

← 1 2 3 4 5 →